February 03, 2010
The FDA has approved Oleptro (trazodone HCl extended-release tablets, from Labopharm), a once-daily formulation of trazodone, for the treatment of major depressive disorder (MDD) in adults.
February 01, 2010
Lilly and the FDA had notified healthcare professionals of changes to the Prescribing Information for Zyprexa (olanzapine) related to its indication for use in adolescents (13-17 years of age) for the treatment of schizophrenia and bipolar I disorder.
January 26, 2010
FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets, and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets due to 'coring,' the cutting or dislodging of silicone cores or slivers from the ports into which they are inserted).
January 11, 2010
Novartis Pharmaceuticals has made available Fanapt (iloperidone) tablets, an atypical antipsychotic, for the acute treatment of schizophrenia in adults.
January 05, 2010
EnVivo Pharmaceuticals announced the initiation and dosing of patients in its Phase 2b study of EVP-6124 for the treatment of schizophrenia.